Adult osteomalacia, unspecified
ICD-10 M83.9 is a billable code used to indicate a diagnosis of adult osteomalacia, unspecified.
Adult osteomalacia is a metabolic bone disorder characterized by the softening of bones due to inadequate mineralization, primarily caused by vitamin D deficiency, malabsorption syndromes, or renal tubular dysfunction. This condition leads to a decrease in bone density and an increased risk of fractures. Patients may present with bone pain, muscle weakness, and an increased susceptibility to fractures, particularly in the vertebrae, pelvis, and long bones. Diagnosis typically involves clinical evaluation, laboratory tests to assess vitamin D levels, and imaging studies such as X-rays or dual-energy X-ray absorptiometry (DEXA) scans to evaluate bone density. Treatment focuses on correcting the underlying cause, which may include vitamin D supplementation, dietary modifications, and addressing any malabsorption issues. The unspecified nature of this code indicates that the specific cause of osteomalacia has not been determined, which can complicate treatment and management strategies.
Detailed lab results, including vitamin D levels and calcium metabolism assessments.
Patients presenting with bone pain, muscle weakness, and abnormal lab results indicating metabolic bone disease.
Endocrinologists must ensure comprehensive documentation of all metabolic factors contributing to osteomalacia.
Comprehensive patient history, including family history of bone disorders and previous fractures.
Patients with chronic pain and a history of vitamin D deficiency or malabsorption syndromes.
Rheumatologists should differentiate between osteomalacia and other inflammatory or degenerative bone diseases.
Used to assess electrolyte levels and kidney function in patients suspected of having osteomalacia.
Document all lab results and their relevance to the diagnosis.
Endocrinologists should ensure that all metabolic factors are evaluated.
Common causes include vitamin D deficiency, malabsorption syndromes, chronic kidney disease, and certain medications that affect bone metabolism.
